California State Teachers Retirement System (CalSTRS)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.91M | Sell |
152,086
-10,490
| -6% | -$216K | ﹤0.01% | 1229 |
|
|
2026
Q1 | $3.12M | Buy |
162,576
+33,167
| +26% | +$660K | ﹤0.01% | 1292 |
|
|
2025
Q4 | $2.14M | Sell |
129,409
-117
| -0.1% | -$1.98K | ﹤0.01% | 1382 |
|
|
2025
Q3 | $1.88M | Buy |
129,526
+10,199
| +9% | +$147K | ﹤0.01% | 1427 |
|
|
2025
Q2 | $1.67M | Buy |
119,327
+1,792
| +2% | +$25.2K | ﹤0.01% | 1460 |
|
|
2025
Q1 | $1.6M | Sell |
117,535
-2,639
| -2% | -$50.6K | ﹤0.01% | 1457 |
|
|
2024
Q4 | $2.45M | Sell |
120,174
-938
| -0.8% | -$24K | ﹤0.01% | 1295 |
|
|
2024
Q3 | $3.53M | Buy |
121,112
+5,158
| +4% | +$128K | ﹤0.01% | 1081 |
|
|
2024
Q2 | $2.69M | Buy |
115,954
+4,518
| +4% | +$86.7K | ﹤0.01% | 1198 |
|
|
2024
Q1 | $2.29M | Sell |
111,436
-5,915
| -5% | -$111K | ﹤0.01% | 1329 |
|
|
2023
Q4 | $2.52M | Sell |
117,351
-5,553
| -5% | -$110K | ﹤0.01% | 1304 |
|
|
2023
Q3 | $2.54M | Sell |
122,904
-12,611
| -9% | -$320K | ﹤0.01% | 1256 |
|
|
2023
Q2 | $4M | Buy |
135,515
+11,503
| +9% | +$323K | 0.01% | 1084 |
|
|
2023
Q1 | $2.86M | Buy |
124,012
+5,431
| +5% | +$149K | ﹤0.01% | 1282 |
|
|
2022
Q4 | $3.3M | Buy |
118,581
+5,618
| +5% | +$167K | 0.01% | 1186 |
|
|
2022
Q3 | $3.47M | Sell |
112,963
-1,921
| -2% | -$62.5K | 0.01% | 1117 |
|
|
2022
Q2 | $3.38M | Buy |
114,884
+8,291
| +8% | +$217K | 0.01% | 1192 |
|
|
2022
Q1 | $3.43M | Sell |
106,593
-9,922
| -9% | -$341K | ﹤0.01% | 1282 |
|
|
2021
Q4 | $5.2M | Buy |
116,515
+2,780
| +2% | +$132K | 0.01% | 1133 |
|
|
2021
Q3 | $5.74M | Sell |
113,735
-11,644
| -9% | -$656K | 0.01% | 1067 |
|
|
2021
Q2 | $9.84M | Buy |
125,379
+30,553
| +32% | +$1.89M | 0.01% | 840 |
|
|
2021
Q1 | $5.42M | Sell |
94,826
-400
| -0.4% | -$26.8K | 0.01% | 1111 |
|
|
2020
Q4 | $7.98M | Buy |
95,226
+35
| +0% | +$2.12K | 0.01% | 859 |
|
|
2020
Q3 | $3.41M | Buy |
95,191
+377
| +0.4% | +$11.4K | 0.01% | 1185 |
|
|
2020
Q2 | $2.29M | Buy |
94,814
+15,571
| +20% | +$366K | ﹤0.01% | 1396 |
|
|
2020
Q1 | $1.39M | Buy |
79,243
+6,555
| +9% | +$137K | ﹤0.01% | 1501 |
|
|
2019
Q4 | $1.27M | Sell |
72,688
-2,026
| -3% | -$33.7K | ﹤0.01% | 1826 |
|
|
2019
Q3 | $1.15M | Buy |
74,714
+892
| +1% | +$17K | ﹤0.01% | 1848 |
|
|
2019
Q2 | $1.53M | Buy |
73,822
+3,542
| +5% | +$79.4K | ﹤0.01% | 1717 |
|
|
2019
Q1 | $1.63M | Sell |
70,280
-2,678
| -4% | -$56K | ﹤0.01% | 1648 |
|
|
2018
Q4 | $1.51M | Buy |
72,958
+3,245
| +5% | +$58.9K | ﹤0.01% | 1658 |
|
|
2018
Q3 | $1.52M | Buy |
69,713
+43,841
| +169% | +$725K | ﹤0.01% | 1807 |
|
|
2018
Q2 | $395K | Buy |
25,872
+1,293
| +5% | +$24.4K | ﹤0.01% | 2579 |
|
|
2018
Q1 | $484K | Buy |
+24,579
| New | +$505K | ﹤0.01% | 2381 |
|
Other funds holding DNLI
California State Teachers Retirement System (CalSTRS)'s DNLI Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Denali Therapeutics (DNLI) stake by 6.5% in Q2 2026, selling an estimated $216K and leaving 152,086 shares worth $3.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1229.
California State Teachers Retirement System (CalSTRS) first reported a position in DNLI in Q1 2018 and has held it in 34 quarters since. The position peaked at $9.84M in Q2 2021. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 152,086 shares of Denali Therapeutics worth $3.91M as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) sold 10,490 Denali Therapeutics shares in Q2 2026, an estimated $216K.
- Denali Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1229 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Denali Therapeutics in Q1 2018 and has held it in 34 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Denali Therapeutics position peaked at $9.84M in Q2 2021.
- 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.